Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Yкраїнський (UK)
Przejdź do strony domowej biblioteki Centralna Biblioteka Wojskowa Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaCentralna Biblioteka Wojskowa

Wyszukujesz frazę "failure" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-15 z 24
Tytuł:
Significance of education and self-management support for patients with chronic heart failure in family physician practice
Autorzy:
Korzh, Oleksii
Krasnokutskiy, Sergiy
Powiązania:
https://bibliotekanauki.pl/articles/551603.pdf
Data publikacji:
2016
Wydawca:
Stowarzyszenie Przyjaciół Medycyny Rodzinnej i Lekarzy Rodzinnych
Tematy:
education
heart failure
self-management.
Źródło:
Family Medicine & Primary Care Review; 2016, 4; 432-436
1734-3402
Pojawia się w:
Family Medicine & Primary Care Review
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Expression profile of circulating microRNAs in patients with ischemic heart failure with moderately reduced left ventricular ejection fraction – pilot study
Autorzy:
Kaufmann, Damian
Daniłowicz-Szymanowicz, Ludmiła
Sakowicz-Burkiewicz, Monika
Szwoch, Małgorzata
Pawełczyk, Tadeusz
Raczak, Grzegorz
Powiązania:
https://bibliotekanauki.pl/articles/895765.pdf
Data publikacji:
2019-02-05
Wydawca:
Gdański Uniwersytet Medyczny
Tematy:
heart failure
circulating microRNAs
biomarkers
Opis:
Introduction: Heart failure (HF) is a growing global pandemic that affects millions of people around the world. Despite the progress in medicine, diagnosis and treatment of HF remains problematic. Recently, noncoding micro ribonucleic acids called miRNAs have become significant in the diagnosis and stratification of HF risk. Aim: The aim of this study was the attempt to identify the profile of circulating miRNAs specific for ischemic HF with moderately reduced left ventricular ejection fraction (HFmrEF). Methods and Results: A number of changes in the miRNA profile can characterise patients with ischemic HFmrEF. This is a pilot study before further research on a larger group of patients. Conclusions: Using the quantitative reverse transcription-polymerase chain reaction (qRT-PCR), serum levels of 84 miRNA were measured and compared between a patient with ischemic HFmrEF and a healthy volunteer. Analysis reveals a down-regulation of let-7f-5p and miR-1-3p, as well as up-regulation of miR-100-5p, miR-10b-5p, miR-125a-5p, miR-140-5p, miR-144-3p, miR-149-5p, miR-15b-5p, miR-183-5p, miR-208b-3p, miR-224-5p, miR-26b-5p, miR-27b-3p, miR-302a-3p, miR-320a, miR-7-5p, miR-99a-5p.
Źródło:
European Journal of Translational and Clinical Medicine; 2018, 1, 2; 53-57
2657-3148
2657-3156
Pojawia się w:
European Journal of Translational and Clinical Medicine
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Mitral regurgitation and its modern treatments
Autorzy:
Pręgowski, Jerzy
Powiązania:
https://bibliotekanauki.pl/articles/1916655.pdf
Data publikacji:
2020
Wydawca:
Polska Akademia Nauk. Czytelnia Czasopism PAN
Tematy:
mitral regurgitation
heart failure
percutaneus intervention
Opis:
Mitral regurgitation is the second most common valvular disease. The etiology is either primary or functional-secondary  to the left ventricle dysfunction in the course of coronary artery disease, arterial hypertension and diabetes. Along with the population aging and increasing number of comorbidities the number of patients with mitral regurgitation soars. In patients with heart failure the mitral regurgitation significantly decreases the quality of life and worsens the survival prognosis. Surgical correction is the treatment of choice in patients with mitral regurgitation. However, up to 50% of potential candidates are denied surgery for its prohibitive risk. The minimally invasive, percutaneus procedures are potential solution for those subjects. Currently the „edge to edge” technique with use of the MitraClip system is most commonly performed. This procedure is less efficient in MR reduction than open heart surgery. However, the number of periprocedural complications is smaller. It has been shown the MR correction with the MitraClip device improves the duration and quality of life. There are several ongoing preclinical studies on the percutaneusly implanted mitral valve prosthesis. First in men procedures have been performed. However the mitral valve anatomy is much more complex as compared to aortic. Therefore the breakthrough comparable to TAVI procedure will not occur in the very close future.
Źródło:
Nauka; 2020, 3
1231-8515
Pojawia się w:
Nauka
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
The impact of renal function on clinical and biochemical characteristics in advanced heart failure patients
Autorzy:
Bohdan, Michał
Frankiewicz, Anna
Gruchała, Marcin
Powiązania:
https://bibliotekanauki.pl/articles/895727.pdf
Data publikacji:
2019-02-05
Wydawca:
Gdański Uniwersytet Medyczny
Tematy:
heart failure
kidney disease
exercise capacity
Opis:
Background: Coexistence of heart failure with reduced ejection fraction (HFrEF) and chronic kidney disease is associated with poor prognosis. We assessed the effect of renal function on exercise capacity and clinical parameters of patients with HF. Material and methods: Forty five patients aged 58.2 ± 10.6 years with stable severe HFrEF were recruited. Patients were divided into 3 groups: group 1 - eGFR: 30-59 ml/min/1.73 m2; group 2 - eGFR: 60-89 ml/min/1.73 m2 and group 3 - eGFR: ≥90 ml/min/1.73 m2. Biochemical analysis, echocardiography, 6-minute walking test and cardiopulmonary stress testing were performed. Results: Patients in group 1 were significantly older than patients in group 3 (60.4 ± 11.1 years vs. 49.25 ± 11.2 years, respectively, p<0.05). Patients in group 2 had significantly higher BMI in comparison to group 3 (29.8 ± 4.4 vs. 25.1 ± 4.2; p<0.05). Interestingly, patients in group 1 had significantly lower peak oxygen uptake (10.2 ± 3.1 ml/kg/min vs. 16.1 ± 3.5 ml/kg/min, p<0.05) and oxygen uptake at anaerobic treshold (7.9 ± 2.4 ml/kg/min vs. 10.7 ± 1.9 ml/kg/min, p<0.05). Conclusions: Diminished renal function in patients with stable, advanced HFrEF may be associated with significantly worse peak VO2 and VO2 in AT.
Źródło:
European Journal of Translational and Clinical Medicine; 2018, 1, 2; 17-22
2657-3148
2657-3156
Pojawia się w:
European Journal of Translational and Clinical Medicine
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Risk factors for poor prognosis in heart failure with particular attention to the elderly population
Autorzy:
Dobrowolska, Małgorzata
Miękus, Paweł
Świątczak, Michał
Raczak, Grzegorz
Daniłowicz-Szymanowicz, Ludmiła
Powiązania:
https://bibliotekanauki.pl/articles/1891021.pdf
Data publikacji:
2021-12-02
Wydawca:
Gdański Uniwersytet Medyczny
Tematy:
heart failure
risk factors
prognosis
elderly
Opis:
Background: Heart failure (HF) is a leading cause of poor outcome. Age is considered one of the most critical risk factors for both the incidence and prognosis of HF. Therefore we aimed to assess the predictors of poor prognosis in HF patients with particular attention to the elderly population. Material and methods: We retrospectively enrolled patients hospitalized due to HF exacerbation during 2016-2017 (203 patients). The end-points were all-cause mortality and emergency rehospitalizations within a two-year follow-up period. A detailed analysis was performed in the subgroups of patients younger and older than 65 years old. Results: 121 (60%) patients experienced the end-points. Age, low systolic blood pressure, NYHA class IV, right ventricle HF symptoms, high C-reactive protein, troponin, NT-proBNP, hyponatremia, catecholamine therapy and mechanical ventilation during hospitalization independently predicted the end-points. The elderly were characterized by a higher incidence of concomitant diseases and HF with moderately reduced or preserved LVEF, worse laboratory parameters and pharmacological treatment, as well as worse prognosis. Conclusion: The prognosis of patients hospitalized due to HF, mainly the elderly, is poor. Simple clinical parameters could be useful in further decision-making regarding the intensification of their treatment.
Źródło:
European Journal of Translational and Clinical Medicine; 2021, 4, 2; 18-30
2657-3148
2657-3156
Pojawia się w:
European Journal of Translational and Clinical Medicine
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Cardiooncological balance in a 75-year-old male with a hepatocellular carcinoma CS IV and a congestive heart failure NYHA III „de novo”
Autorzy:
Żechowicz, Maciej
Wroński, Konrad
Rucińska, Monika
Powiązania:
https://bibliotekanauki.pl/articles/1065186.pdf
Data publikacji:
2015
Wydawca:
Medical Education
Tematy:
cardiooncology
heart failure
hepatocellular carcinoma (HCC)
Opis:
The case reports about a 75-years-old man without a previous medical history, in whom a heart failure NYHA III de novo was diagnosed together with persistent atrial fibrillation and hepatocellular carcinoma in clinical stage IV. Based on echocardiography and computed tomography there were pulmonary hypertension in course of lymphangiosis carcinomatosa as well as diffuse metastases in the abdomen diagnosed. Before the treatment initiation the patient was classified 3 in WHO performance status. After an improvement in control of the rhythm frequency and the heart failure treatment stabilisation with a β-blocker, an ACE-inhibitor, spironolactone and furosemide, the patient’s performance status improved to WHO 2. He was further disqualified from surgical procedures due to the advanced clinical stage of the oncological disease. Considering high probability of further cardiotoxic influence of sorafenib on the heart failure despite its satisfactory control, the patient was assigned to palliative chemotherapy with FOLFOX. Parallel he was strictly followed up cardiologically in an outpatient clinic what certainly supported the oncological treatment. The patient survived 32 weeks from the first hospitalization and the progression free survival was 12 weeks from the chemotherapy initiation.
Źródło:
OncoReview; 2015, 5, 2; A57-61
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Cardiac Rehabilitation in Heart Failure. Part I, Mechanism
Autorzy:
Kujawska, Agnieszka
Husejko, Jakub
Marszałek, Agata
Szczęśniak, Żaneta
Topka, Weronika
Gajos, Małgorzata
Androsiuk-Perkowska, Joanna
Perkowski, Radosław
Natalia, Skierkowska
Kujawski, Sławomir
Kędziora-Kornatowska, Kornelia
Powiązania:
https://bibliotekanauki.pl/articles/1030501.pdf
Data publikacji:
2018
Wydawca:
Uniwersytet Szczeciński. Wydawnictwo Naukowe Uniwersytetu Szczecińskiego
Tematy:
cardiac rehabilitation
exercise training
heart failure
pathophysiology
Opis:
Diagnosis and treatment issues among heart failure (HF) patients are becoming one of the most important points in public health of developed countries, largely due to the aging of population and the fact that HF affects mainly the elderly. In this review we would like to focus on pathophysiology of exercise intolerance in patients with heart failure and potential benefits of cardiac rehabilitation (CR). Analysis of articles in the EBSCO database using keywords: heart failure, cardiac rehabilitation, exercise training, pathophysiology. HF can be described as a composite syndrome which results from structural or functional impairment of ventricular filling or blood ejection. Patients have variety of symptoms which usually are nonspecific. The most frequently occurring symptoms of HF are dyspnea and fatigue, which may restrict exercise capacity, and fluid retention. There are many possible pathophysiological factors involved in the development of exercise intolerance. Based on the available literature pathological changes in central hemodynamic function, pulmonary system, skeletal muscles, endothelial function and neurohumoral system can be distinguished. They play a crucial role in the pathogenesis of HF symptoms and represent a potential curative object. HF patients are characterized by diminished functional performance. Exercise training has many potential profits in patients with heart failure, including an increase in peak oxygen uptake, improvement in central hemodynamics, peripheral vascular and skeletal muscle function and has become part of evidence-based clinical therapy in these patients.
Źródło:
Central European Journal of Sport Sciences and Medicine; 2018, 21, 1; 13-21
2300-9705
2353-2807
Pojawia się w:
Central European Journal of Sport Sciences and Medicine
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Health behaviour of elderly patients with heart failure in Poland associated with pharmacotherapy and non-pharmacological treatment
Autorzy:
Makarewicz-Wujec, Magdalena
Janas, Ewelina
Kozłowska-Wojciechowska, Małgorzata
Powiązania:
https://bibliotekanauki.pl/articles/895264.pdf
Data publikacji:
2019-04-30
Wydawca:
Polskie Towarzystwo Farmaceutyczne
Tematy:
heart failure
health behaviour
adherence
elderly patients
Opis:
Introduction. In Poland, it is estimated that HF is observed in approximately 0,7 million of patients. The aim of the study was to assess health behaviour in geriatric patients diagnosed with HF regarding pharmacotherapy and non-pharmacological treatment. Material and methods. The study group comprised 72 patients with diagnosed HF, over 65y. The study was performed using a questionnaire survey including 20 closed-ended questions. Results. The mean number of medicinal products prescribed by physicians for the treatment of HF and other diseases was 6.59±1.8. 50% of subjects were additionally taking medications and supplements for self-treatment, 63% declared they managed to take medications prescribed on their own. A diet is followed only by 50%, but only 18% limit their sodium intake. 46% still consume alcohol, and 10% of still smoke cigarettes. 46% declared the use of body weight monitoring, but none of them measured their body weight every day. Conclusion. Health behaviour of geriatric patients with HF in Poland indicates their low compliance with medical guidelines and it may explain a high hospitalisation rate and increasing costs of treatment.
Źródło:
Acta Poloniae Pharmaceutica - Drug Research; 2019, 76, 2; 367-374
0001-6837
2353-5288
Pojawia się w:
Acta Poloniae Pharmaceutica - Drug Research
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
His bundle pacing in patients with permanent atrial fibrillation and heart failure with non-reduced ejection fraction – retrospective study
Autorzy:
Skonieczny, Bartosz
Sławuta, Agnieszka
Radziejewska, Jadwiga
Jagielski, Dariusz
Gajek, Jacek
Kozłowski, Dariusz
Powiązania:
https://bibliotekanauki.pl/articles/24987710.pdf
Data publikacji:
2024-01-08
Wydawca:
Gdański Uniwersytet Medyczny
Tematy:
heart failure
permanent atrial fibrillation
His bundle pacing
Opis:
Background: Heart failure [HF] constitutes a complex clinical entity and often coexists with atrial fibrillation [AF]. There is scarcity of evidence-based therapies for those with ejection fraction [EF] ≥ 40%. Effect of regularization of ventricular response in patients with HF with EF ≥ 40% and concomitant atrial fibrillation is unknown. Material and methods: This was a retrospective case-series study. 14 patients with symptomatic HF with EF ≥ 40% and permanent atrial fibrillation who had undergone pHBP were identified and enrolled. For 9 patients pHBP was a primary strategy, for the remaining patients it was an upgrade from right ventricular lead. All patients underwent follow-up visit 3 months after the procedure. Results: NYHA class was significantly reduced (mean 2.5 vs. 1.0, p-value < 0.001). Left ventricular ejection fraction significantly increased mean increase 8.5%, 95% CI 7.7–9.2, p < 0.001) Similarly, significant decrease in left ventricular end diastolic diameter was observed (mean decrease 5.4 mm, 95% CI 5.0–5.8 mm, p < 0.001). The degree of mitral regurgitation after three months was lower (mean grade 2.4 vs. 1.2, p < 0.001). At follow-up prescribed doses of beta blocker were higher (mean metoprolol equivalent dose rose by 69.6 mg). Conclusions: Permanent His bundle pacing might be beneficial in the setting of permanent AF and HF with EF ≥ 40%.
Źródło:
European Journal of Translational and Clinical Medicine; 2023, 6, 2; 45-50
2657-3148
2657-3156
Pojawia się w:
European Journal of Translational and Clinical Medicine
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Stem cells - a new rescue in cardiology?
Autorzy:
Leśniewska, Julia
Gawryś, Jakub
Gawryś, Karolina
Pawelak, Agnieszka
Mikołajczyk, Mikołaj
Powiązania:
https://bibliotekanauki.pl/articles/1178231.pdf
Data publikacji:
2018
Wydawca:
Przedsiębiorstwo Wydawnictw Naukowych Darwin / Scientific Publishing House DARWIN
Tematy:
heart failure
myocardial infarction
stable angina
stem cells
Opis:
In recent years stem cells have become the object of curiosity for many researchers and clinicians. Interest in the use of these cells is an effect of their specific properties. Their great potential for self-renewal as well as the ability to differentiate into specific cell types is particularly interesting. These unique features allow us to think about stem cells as a possible therapeutic solution in the treatment of damaged tissues. The tissue that is particularly vulnerable to damage is heart muscle, which consists of cardiomyocytes. These cells are extremely vulnerable to lack of the oxygen, what can be observed in the case of temporary cardiac ischemia, e.g. during physical exertion or in stressful situations, which initially manifests as stable angina. Prolonged ischemia and consequent hypoxia of cardiomyocytes lead to their death what is manifested as myocardial infarction. An extensive area of post-infarction necrosis impairs heart functioning as a blood pumping organ what leads to its failure. Researchers are still searching for a therapy that would replace large areas of dead cardiomyocytes with new cells, and thus potentially minimize the negative effects of myocardial necrosis and postpone the impairment of its function. Due to their properties, it seems a good idea to introduce stem cells as a method of treatment, hence many studies are conducted to demonstrate the effectiveness of these cells in the treatment of cardiac patients. This paper presents a literature review of stem cell applications in the aforementioned cardiac diseases, taking into account the obtained results.
Źródło:
World Scientific News; 2018, 93; 92-99
2392-2192
Pojawia się w:
World Scientific News
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Impedance cardiography – Old method, new opportunities. Part I. Clinical applications
Autorzy:
Siedlecka, Jadwiga
Siedlecki, Patryk
Bortkiewicz, Alicja
Powiązania:
https://bibliotekanauki.pl/articles/2177029.pdf
Data publikacji:
2015-02-24
Wydawca:
Instytut Medycyny Pracy im. prof. dra Jerzego Nofera w Łodzi
Tematy:
impedance cardiography
hypertension
heart failure
dyspnea
cardiac rehabilitation
Opis:
Monitoring of cardiovascular hemodynamic changes requires a very expensive and highly specialized equipment and skilled medical personnel. Up to the present time, an inexpensive, non-invasive and easy-to-use method which, like Doppler echocardiography, magnetic resonance angiography or radionuclide imaging, would assess hemodynamics of the cardiovascular system was not available. A method known as impedance cardiography (ICG) or thoracic electrical bioimpedance cardiography (TEBC) meets those criteria. It is non-invasive, which is of a particular advantage over the conventional methods that require catheterization. As a result, the patient is not at risk of possible complications and the procedure is less expensive and easier. Impedance cardiography, despite its non-invasive character, has not been so far extensively used for monitoring of hemodynamic parameters in hospitalized patients. Various authors report that attempts have been continued to compare the results from ICG and those obtained by other diagnostic methods. This paper presents the use of impedance cardiography in diagnosis of hypertension, cardiac insufficiency, differentiating the causes of acute dyspnea, as well as in assessing the effects of cardiac rehabilitation in patients with heart failure.
Źródło:
International Journal of Occupational Medicine and Environmental Health; 2015, 28, 1; 27-33
1232-1087
1896-494X
Pojawia się w:
International Journal of Occupational Medicine and Environmental Health
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Serum concentration of visfatin is decreased in patients with chronic heart failure
Autorzy:
Straburzyńska-Migaj, Ewa
Pilaczyńska-Szcześniak, Łucja
Nowak, Alicja
Straburzyńska-Lupa, Anna
Śliwicka, Ewa
Grajek, Stefan
Powiązania:
https://bibliotekanauki.pl/articles/1039706.pdf
Data publikacji:
2012
Wydawca:
Polskie Towarzystwo Biochemiczne
Tematy:
insulin resistance
C-reactive protein
heart failure
lipoproteins
visfatin
Opis:
Background. There is an increasing interest in the role of adipocytokines in cardiovascular pathophysiology. Aim. The aim of the study was to compare visfatin levels, a novel adipokine, in patients with heart failure (HF) due to the left ventricular systolic dysfunction with those in age- and body mass index (BMI) - matched healthy controls in relation to the parameters of glucose metabolism and high sensitivity C-reactive protein (hsCRP) levels. Material/Subjects and Methods. The study population consisted of 28 males with systolic HF referred for cardiopulmonary exercise testing, divided into two subgroups based on their NYHA class (HF patients NYHAI+II, n=17, and HF patients NYHAIII+IV, n=11), and 23 controls. The following indices were measured in a serum samples: visfatin, hsCRP, glucose and lipid metabolism parameters, and the insulin resistance index HOMAIR (homeostasis model assessment insulin resistance) was calculated. Results. Concentrations of visfatin and high-density lipoprotein cholesterol (HDL-cholesterol) in the HF subjects were significantly lower (p≤0.01) than in controls. The Kruskal-Wallis test showed significant differences between three groups (controls and both subgroups of heart failure patients) in mean levels of visfatin, hsCRP, glucose, HOMAIR and HDL-cholesterol. Conclusion. Serum visfatin concentrations in patients with systolic HF, particularly with more advanced NYHA classes, are significantly lower in comparison to healthy controls and are independent of age or anthropometric and metabolic parameters.
Źródło:
Acta Biochimica Polonica; 2012, 59, 3; 339-343
0001-527X
Pojawia się w:
Acta Biochimica Polonica
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Plasma humanin as a prognostic biomarker for canine myxomatous mitral valve disease: a comparison with plasma NT-roBNP
Autorzy:
Mangkhang, K.
Punyapornwithaya, V.
Tankaew, P.
Pongkan, W.
Chattipakorn, N.
Boonyapakorn, C.
Powiązania:
https://bibliotekanauki.pl/articles/2087638.pdf
Data publikacji:
2018
Wydawca:
Polska Akademia Nauk. Czytelnia Czasopism PAN
Tematy:
Humanin
myxomatous mitral valve disease
heart failure
NT-proBNP
ROS
Źródło:
Polish Journal of Veterinary Sciences; 2018, 21, 4; 673-680
1505-1773
Pojawia się w:
Polish Journal of Veterinary Sciences
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Cardiac Rehabilitation in Heart Failure. Part II. Does Higher Intensity Means Better Outcome?
Autorzy:
Kujawska, Agnieszka
Perkowski, Radosław
Skierkowska, Natalia
Topka, Weronika
Gajos, Małgorzata
Androsiuk-Perkowska, Joanna
Cieślińska, Aleksandra
Przybysz, Beata
Kwolik, Dobrawa
Siekacz, Dominika
Rybarczyk, Dominika
Kujawski, Sławomir
Powiązania:
https://bibliotekanauki.pl/articles/1030538.pdf
Data publikacji:
2018
Wydawca:
Uniwersytet Szczeciński. Wydawnictwo Naukowe Uniwersytetu Szczecińskiego
Tematy:
aerobic training
cardiac rehabilitation
heart failure
physical exercise
resistance training
Opis:
Heart failure (HF) due to its universality has become a huge challenge for modern medicine. Second part of the twentieth century brought significant changes in the rehabilitation, diagnostic and pharmacological procedures. There are no definitive guidelines for Cardiac Rehabilitation (CR) in HF. Based on previous studies, the article tried to describe and illustrate the mechanism of effective CR and its intensity in HF patients, which could be helpful in CR protocol development. Cardiac Rehabilitation has confirmed efficacy in increased physical level of participation in inter alia, home/work/recreational activities, improved psychosocial well-being, functional independence, prevention of disability, long-term adherence to maintaining physically active lifestyle, improved cardiopulmonary fitness, strength, muscle endurance, and flexibility, reduced cardiovascular events risk and risk of mortality. Before and after CR conduction, baseline and final aerobic capacity should be examined with an ergospirometry test to evaluate CR protocol intensity and check its effectiveness, respectively. Frequency of training-bouts in CR protocol in HF patients were from 3 to 7 days per week, intensity ranged from 40% to 80% VO2max or 9 to 14 on rating of the perceived exertion (RPE) scale or 6 to 20 on the Borg scale. Duration of single bout-exercise ranged from 20 to 60 minutes.
Źródło:
Central European Journal of Sport Sciences and Medicine; 2018, 22, 2; 23-32
2300-9705
2353-2807
Pojawia się w:
Central European Journal of Sport Sciences and Medicine
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Survival in sudden cardiac arrest in emergency room: case-control study
Przeżywalność w nagłym zatrzymaniu krążenia na szpitalnym oddziale ratunkowym: badanie kliniczno-kontrolne
Autorzy:
Sosnowska-Mlak, Oliwia
Curt, Nicolas
Pinet Peralta, Luis M.
Powiązania:
https://bibliotekanauki.pl/articles/1033048.pdf
Data publikacji:
2019
Wydawca:
Towarzystwo Pomocy Doraźnej
Tematy:
acute coronary syndrome
emergency room
heart failure
sudden cardiac arrest
Opis:
INTRODUCTION: Systematic analysis of risk factors, causes of sudden death and patient survivability allows implementation of increasingly effective methods and procedures for emergency cardiac arrest (SCA). The conditions of the emergency room (ER) allow for initial medical imaging and laboratory diagnostics, which facilitate the assessment of critical parameters that may be a predictor of SCA. The aim of the study is to determine the survival level of patients with SCA that were staying in ER and to indicate the factors that increase the likelihood of SCA. MATERIAL AND METHODS: The study was conducted in 2018 based on medical records of SOR in 73 patients with sudden cardiac arrest in SOR. Descriptive statistics and data analysis were performed using parametric tests (Pearson test). The level of significance was determined for p <0,05. RESULTS: The average age of SOR patients was 72 years (SD ± 16.29). In most cases, the patients were brought to the ER by the EMS. Sinus rhythm dominated in ECG tests,before the onset of SCA,. The ECG mechanisms in which SCA occurred were: asystole (50.7%), PEA (32.9%) and VF / pVT (16.4%), respectively. Among half of the patients (50.7%) of ER spontaneous circulation was restored, while 49.3% of ER patients were fatal. The relationship between mortality and O2 partial pressure, methanol, MPV, D-dimer, pH and HCO3 has been demonstrated. CONCLUSIONS: In the examined group of patients with SCA,non-defibrillatory rhythms (asystole, PEA) dominate. Half of the patients manage to achieve ROSC under ER conditions. There are predictors of SCA in patients in ER.
WSTĘP: Systematyczna analiza czynników ryzyka, przyczyn nagłej śmierci oraz przeżywalności pacjentów pozwala na wdrażanie coraz skuteczniejszych metod i procedur postępowania w nagłym zatrzymaniu krążenia (NZK). Warunki Szpitalnego Oddziału Ratunkowego pozwalają na wstępną diagnostykę obrazową i laboratoryjną, co pozwala na ocenę parametrów krytycznych, mogących stanowić czynnik predykcyjny nagłego zatrzymania krążenia. Celem pracy jest określenie poziomu przeżywalności pacjentów z NZK przebywających w SOR oraz wskazanie czynników wpływających na wzrost prawdopodobieństwa wystąpienia nagłego zgonu sercowego. MATERIAŁ I METODY: Badanie zostało przeprowadzone w 2018 r. na podstawie dokumentacji medycznej SOR-u 73 pacjentów z nagłym zatrzymaniem krążenia na SOR. Dokonano statystyki opisowej oraz analizy danych za pomocą testów parametrycznych (test Pearsona). Poziom istotności ustalono dla p<0,05. WYNIKI: Średnia wieku pacjentów SOR-u wynosiła 72 lata (SD ± 16,29). W większości przypadków chorzy zostali przywiezieni na SOR przez zespół ratownictwa medycznego (ZRM). Przed wystąpieniem NZK w badaniach EKG dominował rytm zatokowy. Mechanizmy EKG, w jakim doszło do NZK to kolejno: asystolia (50,7%), PEA (32,9%) oraz VF/pVT (16,4%). U ponad połowy pacjentów (50,7%) SOR nastąpił powrót spontanicznego krążenia, natomiast u 49,3% pacjentów SOR odnotowano zgon. Wykazano zależność śmiertelności od ciśnienia parcjalnego O2, poziomu metanolu, MPV, D-dimerów, pH oraz HCO3. WNIOSKI: W przebadanej grupie pacjentów z NZK na SOR, zdecydowanie dominują rytmy niedefibrylacyjne (asystolia, PEA). U połowy pacjentów udaje się uzyskać ROSC w warunkach SOR. Istnieją czynniki predykcyjne występowania nagłej śmierci sercowej u pacjentów przebywających w SOR.
Źródło:
Critical Care Innovations; 2019, 2, 3; 1-10
2545-2533
Pojawia się w:
Critical Care Innovations
Dostawca treści:
Biblioteka Nauki
Artykuł
Wyświetlanie 1-15 z 24

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies